Ayala Pharmaceuticals Alpha and Beta Analysis
| ADXSDelisted Stock | USD 0.62 0.03 4.62% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Ayala Pharmaceuticals. It also helps investors analyze the systematic and unsystematic risks associated with investing in Ayala Pharmaceuticals over a specified time horizon. Remember, high Ayala Pharmaceuticals' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Ayala Pharmaceuticals' market risk premium analysis include:
Beta 1.21 | Alpha (0.57) | Risk 0.0 | Sharpe Ratio 0.0 | Expected Return 0.0 |
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Ayala |
Ayala Pharmaceuticals Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Ayala Pharmaceuticals market risk premium is the additional return an investor will receive from holding Ayala Pharmaceuticals long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Ayala Pharmaceuticals. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Ayala Pharmaceuticals' performance over market.| α | -0.57 | β | 1.21 |
Ayala Pharmaceuticals Fundamentals Vs Peers
Comparing Ayala Pharmaceuticals' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Ayala Pharmaceuticals' direct or indirect competition across all of the common fundamentals between Ayala Pharmaceuticals and the related equities. This way, we can detect undervalued stocks with similar characteristics as Ayala Pharmaceuticals or determine the otc stocks which would be an excellent addition to an existing portfolio. Peer analysis of Ayala Pharmaceuticals' fundamental indicators could also be used in its relative valuation, which is a method of valuing Ayala Pharmaceuticals by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Ayala Pharmaceuticals to competition |
| Fundamentals | Ayala Pharmaceuticals | Peer Average |
| Return On Equity | -41.98 | -0.31 |
| Return On Asset | -24.13 | -0.14 |
| Current Valuation | (25.1 M) | 16.62 B |
| Shares Outstanding | 145.64 M | 571.82 M |
| Shares Owned By Insiders | 0.01 % | 10.09 % |
| Shares Owned By Institutions | 0.10 % | 39.21 % |
| Number Of Shares Shorted | 39.89 K | 4.71 M |
Ayala Pharmaceuticals Opportunities
Ayala Pharmaceuticals Return and Market Media
The Stock did not receive any noticable media coverage during the period. Price Growth (%) |
| Timeline |
About Ayala Pharmaceuticals Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Ayala or other otcs. Alpha measures the amount that position in Ayala Pharmaceuticals has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
Ayala Pharmaceuticals Upcoming Company Events
As portrayed in its financial statements, the presentation of Ayala Pharmaceuticals' financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Ayala Pharmaceuticals' leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Ayala Pharmaceuticals' public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Ayala Pharmaceuticals. Please utilize our Beneish M Score to check the likelihood of Ayala Pharmaceuticals' management manipulating its earnings.
| 19th of February 2024 Upcoming Quarterly Report | View | |
| 31st of January 2024 Next Fiscal Quarter End | View |
Build Portfolio with Ayala Pharmaceuticals
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be tightly coupled with the direction of predictive economic indicators such as signals in interest. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Other Consideration for investing in Ayala OTC Stock
If you are still planning to invest in Ayala Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Ayala Pharmaceuticals' history and understand the potential risks before investing.
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Fundamental Analysis View fundamental data based on most recent published financial statements |